A combination of extracellular matrix- and interferon-associated signatures identifies high-grade breast cancers with poor prognosis.

Mol Oncol · 2021 · PMC8096783 · PMID 33523584

Europe PMC DOI

hedged sentence

0.0920

closest p · 1.8× alpha

0.0920

boldest claim

The sentences

borderline significantP = 0.092so close (0.05 < p ≤ 0.1)

Moreover, IHC analysis revealed a borderline significant difference in the proportion of myeloid CD33 + cells in the tumor subgroups (Fisher's exact test; P = 0.092; Fig. 4B ), with the ECM3 + /IFN − subgroup comprising the lowest fraction of HGBCs classified in the CD33 low category, as well as the highest fraction of samples that did not express activation markers (such as PD‐1; Fig. 4C ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.